According to our previous m6A sequencing data, PLOD2 is one of the most significant elevated hyper-methylated m6A transcripts in RCC tissue samples, with a 14.5-fold increase in relative m6A enrichment compared with normal controls. The gene discussed is PLOD2; the disease is renal cell carcinoma.